Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Pathway Pharmacist: Drug Optimisation for Hip Fracture Patients - Facilitating a Safe Patient Handover: a Descriptive Study

NCT03695081 is registered in ClinicalTrials.gov with Sykehuset i Vestfold HF as lead sponsor.

NCT NCT03695081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03695081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Pathway Pharmacist: Drug Optimisation for Hip Fracture Patients - Facilitating a Safe Patient Handover: a Descriptive Study
Lead sponsor
Sykehuset i Vestfold HF
Phase
Not applicable
Overall status
Completed
Start date
September 3, 2018
Completion date
June 28, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, hip fractures, patient fall